| Project |
Indication |
Preclinical |
Clinical phase
I |
Clinical phase
II |
Clinical phase
III |
Registration |
|
Partner |
|
Easyhaler combinations |
Asthma, COPD |
|
|
|
|
|
|
|
|
Stalevo development for Japanese market |
Parkinson's desease |
|
|
|
|
|
|
|
| Androgen receptor antagonist |
Advanced prostate cancer |
|
|
|
|
|
|
Endo Pharmaceuticals |
|
Alpha 2c receptor antagonist |
Alzheimer's disease |
|
|
|
|
|
|
|
| More effective levodopa product |
Parkinson's disease |
|
|
|
|
|
|
|
|
Dexmedetomidine (non-intravenous) |
Pain management |
|
|
|
|
|
|
Rëcro Pharma |
| Androgen receptor antagonist and Alfa 2c receptor antagonist |
Ready for transfer to clinical phase trials if required |
|
|
|
|
|
|
|
Several projects in early research phase |
Prostate cancer, neuropathic pain, Parkinson's disease, Alzheimer's disease etc. |
|
|
|
|
|
|
|